About GenDx
GenDx is a company based in Utrecht (Netherlands) founded in 2005 was acquired by Eurobio scientific in August 2022.. GenDx offers products and services including HLA Typing, Chimerism Monitoring, NGS KIR Typing, NGS MICA, MICB Typing, and Custom Lab Service. GenDx operates in a competitive market with competitors including Omniome, Tessera Therapeutics, HitGen, Phase Genomics and Hexagon Bio, among others.
- Headquarter Utrecht, Netherlands
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Eurobio scientific
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Eurobio scientific
(Aug 17, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GenDx
GenDx offers a comprehensive portfolio of products and services, including HLA Typing, Chimerism Monitoring, NGS KIR Typing, NGS MICA, MICB Typing, and Custom Lab Service. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides gene typing for transplant compatibility and donor matching.
Tracks cell mixtures in patients post-transplantation for health monitoring.
Offers next-generation sequencing for killer cell immunoglobulin receptors.
Performs sequencing for major histocompatibility complex class I chain genes.
Delivers tailored diagnostic solutions for specific research needs.
Funding Insights of GenDx
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2019 | Amount | Series B - GenDx | Valuation | Ampersand Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GenDx
GenDx has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Eurobio scientific and Ampersand Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Founded Year | Domain | Location | |
|
Provider of vitro diagnostic services and products
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GenDx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GenDx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gendx Comparisons
Competitors of GenDx
GenDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Tessera Therapeutics, HitGen, Phase Genomics and Hexagon Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| domain | founded_year | HQ Location |
New genome engineering technology is provided for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| domain | founded_year | HQ Location |
Laboratory and computational services for DNA proximity analysis are provided.
|
|
| domain | founded_year | HQ Location |
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
|
|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gendx
Frequently Asked Questions about GenDx
When was GenDx founded?
GenDx was founded in 2005 and raised its 1st funding round 14 years after it was founded.
Where is GenDx located?
GenDx is headquartered in Utrecht, Netherlands.
What does GenDx do?
GenDx was founded in 2005 in Utrecht, Netherlands, within the in vitro diagnostics sector. Products focused on HLA typing for transplant applications are developed and marketed, including reagents and kits for Sanger sequencing and next-generation sequencing. Analysis software for sequencing data is also provided, alongside educational services to support clinical and research use. Operations emphasize precision in transplant compatibility assessments.
Who are the top competitors of GenDx?
GenDx's top competitors include Tessera Therapeutics, Novogene Corporation and Phase Genomics.
What products or services does GenDx offer?
GenDx offers HLA Typing, Chimerism Monitoring, NGS KIR Typing, NGS MICA, MICB Typing, and Custom Lab Service.
Who are GenDx's investors?
GenDx has 2 investors. Key investors include Eurobio scientific, and Ampersand Capital Partners.